The recoveryELISA - A newly developed immunoassay for measurement of therapeutic antibodies and the target antigen during antibody therapy

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 7, 2012, Pages 1263-1269

  Strohner, Pavel ^a   Staatz, Antonia ^a   Sarrach, Dieter ^a   Steiss, Jens Oliver ^b   Becher, Gunther ^c  

^a BioTeZ Berlin Buch GmbH   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c BecherConsult GmbH   (Germany)

Author keywords

Antibody therapy; Enzyme immunoassay; Therapeutic antibodies

Indexed keywords

IMMUNOGLOBULIN E; OMALIZUMAB;

ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOTHERAPY; IN VITRO STUDY; PRIORITY JOURNAL; RECOVERY ENZYME LINKED IMMUNOSORBENT ASSAY;

ANTIBODIES; ANTIBODIES, MONOCLONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS;

EID: 84866293841     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2011-0644     Document Type: Article

References (12)

1. Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Cioppa GD, et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 2001;108:184-90.
2. Bousquet J, Wenzel S, Holgate S, Lumry W, Freeman P, Fox H. Predicting response to Omalizumab, an anti-IgE antibody, in patients with allergic asthma. Chest 2004;125:1378-86.
3. Ruffin CG, Busch BE. Omalizumab: a recombinant humanized anti-IgE antibody for allergic asthma. Am J Health Syst Pharm 2004;61:1449-59.
4. Reich JG. C curve fitting and modeling for scientists and engineers. New York: McGraw-Hill, 1991.
5. Strohner P, Sarrach D, Reich JG. Use of a modified binding model for the investigation of affinity dependence on antibody concentration in immunoassay systems. J Immunol Methods 1997;203:113-22.
6. Korn S, Haasler I, Jung M, Strohner P, Staatz A, Schaefer A, et al. Free serum IgE in patients with severe allergic asthma treated with Omalizumab. J Respir Crit Care Med 2010;181:A6655.
7. Hamilton RG, Marcotte GV, Saini SS. Immunological methods for quantifying free and total serum IgE levels in allergy patients receiving Omalizumab (Xolair) therapy. J Immunol Methods 2005;303:81-91.
8. Beum PV, Kennedy AD, Taylor RP. Three new assays for rituximab based on its immunological activity or antigenic properties: analyses of sera and plasmas of RTX-treated patients with chronic lymphocytic leukemia and other B cell lymphomas. J Immunol Methods 2004;289:97-109.
9. Jilani I, Keating M, Giles FJ, O'Brien S, Kantarjian HM, Albitar M. Alemtuzumab: validation of a sensitive and simple enzymelinked immunosorbent assay. Leuk Res 2004;28:1255-62.
10. Feldman HA. Mathematical theory of complex ligand-binding systems at equilibrium: some methods for parameter fitting. Anal Biochem 1972;48:317-38.
11. Gosling JP. Enzyme immunoassay: with and without separation. In: Price CP, Newman DJ, editors. Principles and practice of Immunoassay. 2nd ed. London: MacMillan, 1997:351-88.
12. Stenberg M, Nygren H. Kinetics of antigen-antibody reaction at solid-liquid interfaces. J Immunol Methods 1988;113:3-15.